Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC. (Q36673751)
Jump to navigation
Jump to search
scientific article published on 5 March 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC. |
scientific article published on 5 March 2013 |
Statements
1 reference
Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC. (English)
1 reference
Valerie Nelson
1 reference
Jacqueline Ziehr
1 reference
Mark Agulnik
1 reference
Melissa Johnson
1 reference
1 reference
Identifiers
1 reference